ZAJohnson & Johnson has announced a $5.5 billion settlement with approximately 69,000 plaintiffs who claimed its talc products caused ovarian cancer. The agreement, which covers most remaining talc-related claims in both federal and state courts, requires approval from 95% of affected claimants. J&J's vice president described the claims as 'meritless' and stated the settlement aims to provide closure. The company previously won a court ruling that questioned plaintiffs' ability to prove a direct causal link between talc and ovarian cancer. Despite ongoing litigation, J&J has ceased selling talc-based baby powder in the U.S., opting for cornstarch alternatives. The settlement does not cover future lawsuits.
Bias read (Center): The article presents a balanced account of the legal dispute, including statements from both the plaintiffs' law firms and J&J executives. It reports on the settlement terms, court rulings, and corporate actions without overtly favoring either side. While the issue of product liability is inherently
